Skip to content
Issue / June 2026
Menu
Gut Metabolic

A food-science magazine on the gut microbiome and metabolic health — every claim sourced.

Feature

Urolithin A Dosage: What the Human Trials Actually Used

Urolithin A has real human RCT dosing — trials used roughly 500–1,000 mg/day. Here's what those studies actually used, and what's still unsettled.

By Priya Raman

Nutrition & Microbiome Editor ·

Most supplement "dosages" are guesses dressed up as guidance — a number a brand chose, loosely inspired by a cell-culture study, then printed on a label. Urolithin A is one of the rare exceptions: it has actual randomized human trials, and those trials used defined daily doses while measuring real mitochondrial and muscle endpoints. So unlike most ingredients, there's a genuine anchor for "how much" — not a regulator-set dose, but the doses that produced the published human results. This page reports what those trials used, why supplementing makes sense at all (hint: your gut may not make urolithin A on its own), why more isn't proven to be better, and what's still genuinely unsettled.

If you want the full benefits-and-side-effects picture first, start with our urolithin A evidence review; if you've already decided to buy, the best urolithin A supplement roundup covers which products match the tested form. This page is narrowly about dose.

Why there's a dose to anchor to at all

Here's the part that makes urolithin A unusual. You can't really eat it directly — what you eat are ellagitannins and ellagic acid, the polyphenols in pomegranates, walnuts, and berries. Your gut bacteria then convert those into urolithins 1. The catch is that not everyone's gut can do this: the producing bacteria are specific, people fall into different "metabotypes," and a substantial fraction are low or non-producers 1. That's the core rationale for a supplement — a direct dose of urolithin A bypasses the lottery of whether your microbiome makes it from food.

And because the molecule was studied as a supplement, researchers had to pick doses and test them in people. That's why we can talk about urolithin A dosage with more honesty than almost any other longevity ingredient: the numbers below aren't invented, they're what the trials administered.

What the trials used

Roughly 500–1,000 mg/day, once daily, over weeks

  • The human trials used about 500 to 1,000 mg of urolithin A per day, taken once daily with food.
  • This range comes from the actual studies — there is no official or regulator-set dose.
  • The benefit is a sustained-use effect over weeks, so daily consistency matters more than time of day.
  • More isn't proven to be better: the trials showed modest effects at the tested doses, not a bigger-is-better curve.
  • Long-term optimal dosing, and whether it should differ by producer vs. non-producer, is still unsettled.

What the human trials actually used

Across the published human work, urolithin A dosing clusters in a clear range: roughly 500 mg to 1,000 mg per day, taken orally, once daily, over weeks to months.

First-in-human (safety + mitochondrial signature). The first-in-human study established that oral urolithin A is safe and bioavailable, and that it induced a molecular signature of improved mitochondrial and cellular health in older adults — without serious adverse events 2. That study is the reason "is this even safe at a real dose?" has a credible answer.

Muscle and exercise RCTs. The two randomized controlled trials that carry the functional case both used doses in this range. In middle-aged adults, urolithin A improved muscle strength and some exercise-performance and mitochondrial biomarkers versus placebo 3. In older adults, a randomized trial found improvements in muscle endurance and mitochondrial-health markers 4. These were daily-dosing, multi-week designs — the effects built over sustained use, not from a single dose.

That's the honest envelope: 500–1,000 mg/day, once daily, over weeks, is the dosing that produced the published human muscle and mitochondrial results. There is no official or regulator-set dose; this is a trial-derived convention, not a prescription.

Dose by study

StudyDaily dosePatternWhat it found
First-in-human safety (Andreux 2019)~500–1,000 mgOral, dailySafe + bioavailable; mitochondrial-health signature in older adults
RCT, middle-aged adults (Singh 2022)~500–1,000 mgOnce daily, weeksImproved muscle strength + mitochondrial biomarkers vs placebo
RCT, older adults (Liu 2022)~500–1,000 mgOnce daily, weeksImproved muscle endurance + mitochondrial-health markers
The published human trials cluster around 500–1,000 mg/day, dosed once daily over weeks. Effects were modest and specific — muscle and mitochondrial markers.

"Once daily with food" — and why timing barely matters

The trials dosed urolithin A once daily, and it's typically taken with food. But the more important point is mechanistic: the benefit is a sustained-use phenomenon, not an acute hit. The trials ran for weeks to months precisely because the effect accumulates. That makes "best time of day" largely a question of consistency — taking it reliably every day matters far more than whether it's morning or evening. If a particular time helps you remember it, that's the right time.

Why more isn't proven to be better

It's tempting to assume that if 500 mg helps, 1,000 mg helps twice as much, and 2,000 mg more still. The evidence doesn't support that leap. The trials tested specific doses and found modest, specific benefits — muscle and mitochondrial markers in middle-aged and older adults 34. They did not establish a dose-response curve where bigger reliably means better, and they certainly didn't validate megadoses. Pushing above the studied range means leaving the evidence behind entirely: you're no longer taking "the dose the trials used," you're improvising. Given that the proven benefits are modest even at the tested doses, there's no data-backed reason to chase higher numbers — and the long-term safety record only covers the studied range.

What's still unsettled

Honesty requires flagging what the dosing data don't tell us:

  • The long-term optimal dose is unknown. Trials ran weeks to months, not years. Whether 500 mg or 1,000 mg is "better" long-term, or whether a maintenance dose differs from a starting dose, simply hasn't been established.
  • Producers vs. non-producers. The supplement rationale is strongest for low producers, but trials didn't tailor dose to metabotype — everyone got the study dose. Whether a natural producer needs the same amount as a non-producer is unresolved.
  • No dosing for special populations. Pregnancy, breastfeeding, and people on medication or with health conditions weren't studied, so there's no evidence-based dose for them. Check with a clinician.

Treat any label dose as a manufacturer convention informed by — but not identical to — the trial doses. The useful anchor is the trial range itself, not a brand's rounding of it.

The honest bottom line

What the trials used

Roughly 500–1,000 mg/day, once daily, over weeks

  • The human trials used about 500 to 1,000 mg of urolithin A per day, taken once daily with food.
  • This range comes from the actual studies — there is no official or regulator-set dose.
  • The benefit is a sustained-use effect over weeks, so daily consistency matters more than time of day.
  • More isn't proven to be better: the trials showed modest effects at the tested doses, not a bigger-is-better curve.
  • Long-term optimal dosing, and whether it should differ by producer vs. non-producer, is still unsettled.

Urolithin A is one of the few supplements where "how much should I take?" has a real answer grounded in human trials: roughly 500 to 1,000 mg per day, once daily, taken over weeks of consistent use — the doses that produced the published muscle and mitochondrial-marker results. The supplement exists because many people's gut bacteria can't make meaningful urolithin A from food. But the proven benefits are modest, more isn't shown to be better, and the long-term optimal dose remains unsettled. Anchor to the trial range, don't chase megadoses, and pick a product that actually states its milligrams — our best urolithin A supplement guide covers that. For where urolithin A sits among gut-derived compounds, see our best gut health supplements hub and, for another gut-made metabolite with a similar mechanism-versus-proof gap, butyrate supplements and foods. And to run the numbers on a stated dose, our tools can help.

Urolithin A has real human RCT dosing — trials used roughly 500–1,000 mg/day. Here's what those studies actually used, and what's still unsettled.
Gut Metabolic — the short version

Reader questions

How much urolithin A should I take per day?

The published human trials used roughly 500 to 1,000 mg of urolithin A per day, taken once daily. That range is the most honest anchor because it's what actually produced the muscle and mitochondrial-marker results in the randomized studies. There's no official or regulator-set dose, so treat label dosing as a manufacturer convention informed by — but not identical to — the trial doses, and check with a clinician if you take medications or have a health condition.

When is the best time to take urolithin A?

The trials dosed it once daily, typically with food. Because the benefit builds over weeks of consistent use rather than acutely, the time of day matters far less than taking it regularly. Pick whatever time helps you stay consistent.

Is more urolithin A better?

There's no evidence that it is. The trials found modest, specific benefits — muscle and mitochondrial markers in middle-aged and older adults — at doses around 500 to 1,000 mg/day. They didn't establish that higher doses work better, and going above the studied range means leaving the human evidence (and the documented safety record) behind. There's no data-backed reason to chase megadoses.

Why take a urolithin A supplement instead of eating pomegranates?

You can supply the precursors — ellagitannins and ellagic acid in pomegranates, walnuts, and berries — but whether your gut converts them into urolithin A depends on your microbiome, and many people are low or non-producers. A direct supplement bypasses that conversion lottery, which is exactly why trials gave a defined oral dose rather than relying on food.

Is the urolithin A dose the same for everyone?

The trials gave the study dose to all participants regardless of whether they were natural producers, so dosing tailored to metabotype hasn't been established. Long-term optimal dosing — and whether a maintenance dose should differ from a starting dose — is also unsettled, since trials ran weeks to months, not years. Special populations like pregnant or breastfeeding people weren't studied at all and should consult a clinician.

Sources

  1. García-Villalba R, Giménez-Bastida JA, Cortés-Martín A, et al. (2022). Urolithins: a Comprehensive Update on their Metabolism, Bioactivity, and Associated Gut Microbiota. Molecular Nutrition & Food Research. https://pubmed.ncbi.nlm.nih.gov/35118817/
  2. Andreux PA, Blanco-Bose W, Ryu D, et al. (2019). The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans. Nature Metabolism. https://pubmed.ncbi.nlm.nih.gov/32694802/
  3. Singh A, D'Amico D, Andreux PA, et al. (2022). Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults. Cell Reports Medicine. https://pubmed.ncbi.nlm.nih.gov/35584623/
  4. Liu S, D'Amico D, Shankland E, et al. (2022). Effect of Urolithin A Supplementation on Muscle Endurance and Mitochondrial Health in Older Adults: A Randomized Clinical Trial. JAMA Network Open. https://pubmed.ncbi.nlm.nih.gov/35050355/

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.

Also in this issue